MedPath

Stanford Cardiac Invasive Electrophysiology Novel Computer Experience

Completed
Conditions
Atrial Tachycardia
Atrial Fibrillation
Atrial Flutter
Arrhythmias, Cardiac
Interventions
Diagnostic Test: No Intervention. Test is computer algorithm.
Registration Number
NCT03549806
Lead Sponsor
Stanford University
Brief Summary

This study will test the ability of computer algorithms to predict successful ablation therapy for atrial arrhythmias.

Detailed Description

Patients will be recruited prospectively from among those undergoing ablation for atrial fibrillation (AF) or atrial tachycardias (AT) which may be reentrant or focal. Each patient will undergo careful data collection, including electrogram data and sites of ablation lesions. Ablation will proceed in operator-dependent fashion, and will not be modified in any way for this study. The research question is whether algorithms based on data such as electrograms and details of the ablation performed can predict which patients will have a successful case. Primary endpoints are measures of clinical success defined by (a) acute termination of atrial arrhythmia during the case; (b) long-term reduction in arrhythmia burden; (c) long-term freedom from arrhythmia. Secondary endpoints include (a) identification of sites of arrhythmia termination; (b) improved clinical status.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Patients undergoing catheter ablation for atrial arrhythmias
Read More
Exclusion Criteria
  • Inability to sign informed consent
  • Expected survival < 1 year
  • Extreme comorbidity, such as advanced NYHA Class III/IV heart failure, dialysis, series stroke.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Prospective CohortNo Intervention. Test is computer algorithm.No study intervention. Patients referred for ablation of atrial arrhythmias will be treated as per operator preference with no study intervention. Data will be collected in de-identified fashion.
Primary Outcome Measures
NameTimeMethod
Freedom from arrhythmia on follow-up2 years

Absence of arrhythmia, defined by clinical thresholds.

Reduction in AF burden on follow-up2 years

Reduction in amount of arrhythmia per unit time, compared to prior to the procedure.

Secondary Outcome Measures
NameTimeMethod
Clinical status as measured by the EQ5D2 years

Patient feeling better subjectively in EQ5D

Trial Locations

Locations (1)

Stanford Hospital

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath